APA (7th ed.) Citation

Hübner, M., Hinske, C., Effinger, D., Kreth, F., & Kreth, S. (2018). CSIG-16. INTRONIC miR-744 INHIBITS GLIOBLASTOMA INVASION THROUGH INHIBITION OF MAPK-, SMAD- AND BETA-CATENIN SIGNALING. Neuro-oncology, 20, vi46. https://doi.org/10.1093/neuonc/noy148.182

Chicago Style (17th ed.) Citation

Hübner, Max, Christian Hinske, David Effinger, Friedrich-Wilhelm Kreth, and Simone Kreth. "CSIG-16. INTRONIC MiR-744 INHIBITS GLIOBLASTOMA INVASION THROUGH INHIBITION OF MAPK-, SMAD- AND BETA-CATENIN SIGNALING." Neuro-oncology 20 (2018): vi46. https://doi.org/10.1093/neuonc/noy148.182.

MLA (9th ed.) Citation

Hübner, Max, et al. "CSIG-16. INTRONIC MiR-744 INHIBITS GLIOBLASTOMA INVASION THROUGH INHIBITION OF MAPK-, SMAD- AND BETA-CATENIN SIGNALING." Neuro-oncology, vol. 20, 2018, p. vi46, https://doi.org/10.1093/neuonc/noy148.182.